FEATURES OF ENDOCERVICAL ADENOCARCINOMA IN RELATION TO SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX
Abstract
Cervical adenocarcinoma poses a huge diagnostic and therapeutic problem due to its endocervical localization and specific etiopathogenesis. Aims of the paper were: to establish characteristics of cervical adenocarcinoma in comparison to squamous cell type, to assess the validity of current diagnostic methods in cervical adenocarcinoma diagnostics, and to determine the best combination of diagnostic procedures that reduce the percentage of false negative results and demonstrate high sensitivity in cervical adenocarcinoma diagnostics. This was a prospective study comprising 180 patients operated for high-grade cervical intraepithelial neoplasia II and III, adenocarcinoma in situ and cervical carcinoma at the Clinic of Gyneacology and Obstetrics, University Clinical Center Niš.
The objective of our study was especially focused on patients with a histological diagnosis of adenocarcinoma. All the patients filled out a questionnaire prior to surgery and samples for human papilloma virus (HPV) testing were collected from all of them. HPV typing was performed at the Public Health Institute Niš, by using PCR method for detecting oncogenic HPV types and genotypes. HPV result was statistically significantly more commonly associated with adenocarcinoma. NILM finding was statistically significantly more commonly associated with AC pathohistological finding, while other cytological findings were statistically significantly more commonly associated with other PH results. Normal colposcopic finding was more commonly associated with AC pathohistological finding. Irregular bleeding finding in relation to defined groups of pathological finding is statistically significant and demonstrates medium strength of association. Irregular bleedings are statistically significantly more common in adenocarcinoma in comparison to severe forms of squamous changes.
References
Andersson S, Rylander E, Larsson B, Strand A, Silfversvärd C, Wilander E. The role of human papillo-mavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001;37(2):246-50. [CrossRef] [PubMed]
Dahlström LA, Ylitalo N, Sundström K, Palmgren J, Ploner A, Eloranta S, et al. Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer 2010;127(8):1923-30. [CrossRef] [PubMed]
Eide TJ. Cancer of the uterine cervix in Norway by histologic type, 1970-84. J Natl Cancer Inst 1987; 79(2):199-205. [PubMed]
Etherington IJ, Luesley DM. Adenocarcinoma in situ of the cervix - controversies in diagnosis and treatment. J Low Genit Tract Dis 2001;5(2):94-8. [CrossRef] [PubMed]
Gustafsson L, Pontén J, Zack M, Adami HO. Inter-national incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997;8(5):755-63. [CrossRef] [PubMed]
Gyllensten U, Lindell M, Gustafsson I, Wilander E. HPV test shows low sensitivity of Pap screen in older women. Lancet Oncol 2010;11(6):509-10. [CrossRef] [PubMed]
Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, et al. Gastric morphology and immune-phenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 2007;31(5):664-72. [CrossRef] [PubMed]
Moll UM, Chalas E, Auguste M, Meaney D, Chumas J. Uterine papillary serous carcinoma evolves via a p53-driven pathway. Hum Pathol 1996;27(12):1295-300. [CrossRef] [PubMed]
Park KJ, Kiyokawa T, Soslow RA, Lamb CA, Oliva E, Zivanovic O, et al. Unusual endocervical adenocarcino-mas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol 2011;35(5):633-46. [CrossRef] [PubMed]
Pettersson BF, Andersson S, Hellman K, Hellström AC. Invasive carcinoma of the uterine cervix associated with pregnancy: 90 years of experience. Cancer 2010; 116(10):2343-9. [CrossRef][ PubMed]
Renshaw AA, Mody DR, Lozano RL, Volk EE, Walsh MK, Davey DD, et al. Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: Comparison of diagnostic accuracy with other high-grade lesions. Arch Pathol Lab Med 2004;128(2):153-7. [CrossRef] [PubMed]
Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. New Technologies for Cervical Cancer screening (NTCC) Working Group: Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11(3):249-57. [CrossRef] [PubMed]
Tornesella ML, Buonaguro L, Giorgi-Rossi P, Buonaguro F. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed Res Int 2013;2013:519619. [CrossRef] [PubMed]
Vizcaino AP, Moreno V, Bosch FX, Muñoz N, Barros-Dios XM, Borras J, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000;86(3):429-35. [CrossRef] [PubMed]
